SWANSEA, Wales, April 22, 2014 /PRNewswire/ --
Creates Cellnovo
France
Cellnovo, the leading innovator in Mobile Diabetes Management
and insulin patch pump technologies, announces the appointments of
three experienced executives to the senior management team.
Bart Bergstein has been appointed as
Chief Financial Officer, Steve
Bubrick as Vice President Global Marketing and Business
Development, and Didier Moire as Area Director of newly created
Cellnovo France.
Bart Bergstein has a 24 year
track record in the financial industry including 14 years in
Venture Capital. After joining the private equity arm of
ABN AMRO in 1997, Bart established
the AMRO Life Sciences Team that later spun out as Forbion Capital
Partners.
Steve Bubrick has more than 20
years of experience in the diabetes industry. He joins Cellnovo
from Asante Solutions where he held the position of Vice President
Commercial Operations. Prior to Asante, Steve held senior
commercial positions at Insulet, Abbott, Therasense and Lifescan
where he was involved in bringing disruptive monitoring and insulin
delivery products to markets worldwide. Steve will also be in
charge of laying the foundations of Cellnovo's business in
North America, starting with
overseeing its regulatory filing process.
Recognising the importance of the diabetes market in
France, Cellnovo has created a
subsidiary in the country with an office in Paris, where Didier Moire will be based and
responsible for sales in France,
Belgium and Luxembourg. Didier has more than 25 years'
experience in Medical Technology and Diagnostics. He was previously
Managing Director France/Benelux for Immucor and also held senior
positions in Chiron and Novartis.
Eric A. Beard, Executive Chairman
of Cellnovo, said: "I am absolutely delighted to welcome
Bart, Steve and Didier to the Cellnovo senior management team. All
three are experienced executives and entrepreneurs who will be
major contributors to the success of the Company and the launch of
our novel insulin delivery and diabetes management
technologies."
About Cellnovo
Cellnovo, a UK-based medical device company, is a leading
innovator in Mobile Diabetes Management technology. The Company's
proprietary Diabetes Management System comprises a wireless
connected patch pump, mobile touchscreen handset/controller with an
integrated blood glucose meter and applications. This system
provides intuitive operation, wireless Internet connectivity and
real-time tracking, all industry firsts which represent a
revolution for insulin pump technology. For further information,
please visit http://www.cellnovo.com.
SOURCE Cellnovo